Skip to content
10-Q

Quarterly Report

Westlake Chemical Partners LP WLKP

0001604665-26-000017

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 35.25M sh
Capex Q1 2026 · Mar 31, 2026 $5.56M
Capex Q1 2026 · Mar 31, 2025 $15.96M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $110.2M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $45.78M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $44.29M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $44.27M
Current Liabilities Q1 2026 · Mar 31, 2026 $40.79M
Current Liabilities Q1 2026 · Dec 31, 2025 $51.3M
Total Liabilities Q1 2026 · Mar 31, 2026 $443.31M
Total Liabilities Q1 2026 · Dec 31, 2025 $454.18M
Current Assets Q1 2026 · Mar 31, 2026 $148.9M
Current Assets Q1 2026 · Dec 31, 2025 $143.51M
Total Assets Q1 2026 · Mar 31, 2026 $1.24B
Total Assets Q1 2026 · Dec 31, 2025 $1.26B
Sga Expense Q1 2026 · Mar 31, 2026 $7.19M
Sga Expense Q1 2026 · Mar 31, 2025 $7.47M
Net Income Q1 2026 · Mar 31, 2026 $14.17M
Net Income Q1 2026 · Mar 31, 2025 $4.95M
Operating Income Q1 2026 · Mar 31, 2026 $86.57M
Operating Income Q1 2026 · Mar 31, 2025 $46.61M
Gross Profit Q1 2026 · Mar 31, 2026 $93.76M
Gross Profit Q1 2026 · Mar 31, 2025 $54.08M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $211.92M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $183.55M